Compare Humana Inc (HUM) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs State Street SPDR S&P Homebuilders ETF — how do they compare? Humana Inc trades at $407.03 (market cap $47.81B), while State Street SPDR S&P Homebuilders ETF trades at $106.19. The key difference: Humana Inc pays a 0.89% dividend while State Street SPDR S&P Homebuilders ETF pays none, and Humana Inc is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals.
| HUM | XHB | |
|---|---|---|
Market Cap | $47.81B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $409.42 | $121.36 |
52-Week Low | $163.67 | $94.86 |
Enterprise Value | $56.85B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
XHB trades at $106.07, down 2.01% today amid a bearish technical signal with moving averages indicating selling pressure. The ETF faces mixed housing data, with June home sales declining but new legislation potentially boosting homebuilders. Key support lies at $104, while resistance is at $110. Financial ratios are unavailable, but sentiment is influenced by macroeconomic factors like mortgage rates and housing affordability.
Outlook remains cautious due to high mortgage rates and volatile home sales, though regulatory support offers upside potential. Risks include interest rate sensitivity and economic slowdowns. Investors should weigh technical weakness against long-term housing demand drivers for balanced exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
